|Videos|June 29, 2022
Future Perspectives in Renal Cell Carcinoma (RCC)
Author(s)Thomas Hutson, DO, PharmD
Dr Thomas Hutson comments on the TiNivo-2 trial and discusses upcoming and novel therapies for patients with renal cell carcinoma.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Trending on CURE
1
B7-H3 CAR T-Cell Therapy Shows Acceptable Safety in Recurrent Glioblastoma
2
Giredestrant Shows Benefit for Early Breast Cancer in Phase 3 Trial
3
Early Real-World Uptake of Voranigo in Patients With IDH-Mutant Glioma
4
Voranigo Plus Temodar Found to Be Safe in Patients With IDH1/2+ Glioma
5
